Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TN/Memphis
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Memphis, TN

Studies commonly pay $75 to $4,500 per completed study

583 clinical trials are currently recruiting participants within 30 miles of Memphis. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

583studies recruiting
1+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Memphis right now

Top 25 of 583 recruiting studies, sorted by proximity — each links to its official registry page

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications Phase 3 Interventional 115 participants sought
Saint Jude Children's Research Hospital (Pediatrics only) — Memphis, Tennessee (5.5 mi) · Sponsor: Pierre Fabre Medicament
See eligibility & contact on ClinicalTrials.gov (NCT03394365)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Charles Retina Institute — Germantown, Tennessee (9.0 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer, c-MET Phase 3 Interventional 768 participants sought
Duplicate_Memphis VA Medical Center /ID# 263250 — Memphis, Tennessee (5.5 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT04928846)

NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study

Intracranial Aneurysm N/A Observational 118 participants sought
Semmes Murphey Clinic/Semmes Murphy Foundation — Memphis, Tennessee (5.5 mi) · Sponsor: Medtronic Neurovascular Clinical Affairs
See eligibility & contact on ClinicalTrials.gov (NCT06604884)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Memphis, Tennessee (5.5 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
Stern Cardiovascular — Southaven, Mississippi (8.7 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT06909565)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Memphis, Tennessee (5.5 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07129993)

ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

Dravet Syndrome Phase 1, Phase 2 Interventional 32 participants sought
Le Bonheur Children's Hospital — Memphis, Tennessee (5.5 mi) · Sponsor: Ionis Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07531745)

Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)

Low-Risk, Early Stage Breast Cancer N/A Interventional 400 participants sought
The West Clinic, PC dba West Cancer Center — Germantown, Tennessee (9.0 mi) · Sponsor: IceCure Medical Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07629206)

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

HIV Infection Phase 1, Phase 2 Interventional 1,120 participants sought
6501, St Jude Children's Research Hospital Clinical Research Site — Memphis, Tennessee (5.5 mi) · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
See eligibility & contact on ClinicalTrials.gov (NCT02140255)

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Solid Tumors, Hematologic Malignancies Phase 3 Interventional 3,500 participants sought
West Cancer Center and Research Institute ( Site 0055) — Germantown, Tennessee (9.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT03486873)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Baptist Memorial Hospital and Cancer Center-Memphis — Memphis, Tennessee (5.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Papillary Thyroid Cancer, Pediatric Cancer N/A Observational 32 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi) · Sponsor: Children's Hospital of Philadelphia
See eligibility & contact on ClinicalTrials.gov (NCT05024929)

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer Phase 3 Interventional 450 participants sought
West Cancer Center — Germantown, Tennessee (9.0 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06790693)

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Acute Myeloid Leukemia (AML) Phase 3 Interventional 1,300 participants sought
Baptist Clinical Research Institute — Memphis, Tennessee (5.5 mi) · Sponsor: Kura Oncology, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07007312)

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer Phase 3 Interventional 1,000 participants sought
The West Clinic, PLLC dba West Cancer Center — Germantown, Tennessee (9.0 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07028853)

A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

Neuroblastoma Recurrent Phase 2 Interventional 54 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi) · Sponsor: St. Jude Children's Research Hospital
See eligibility & contact on ClinicalTrials.gov (NCT07085338)

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

Charcot Marie Tooth Disease N/A Observational 5,000 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi) · Sponsor: Michael Shy
See eligibility & contact on ClinicalTrials.gov (NCT01193075)

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis N/A Observational 400 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi) · Sponsor: Arkansas Children's Hospital Research Institute
See eligibility & contact on ClinicalTrials.gov (NCT03827694)

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma Phase 2 Interventional 90 participants sought
NACHO Consortium — Memphis, Tennessee (5.5 mi) · Sponsor: Carl Allen
See eligibility & contact on ClinicalTrials.gov (NCT04079179)

Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory Phase 1 Interventional 60 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi) · Sponsor: St. Jude Children's Research Hospital
See eligibility & contact on ClinicalTrials.gov (NCT04881240)

Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors

Brain Tumor N/A Interventional 45 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi) · Sponsor: St. Jude Children's Research Hospital
See eligibility & contact on ClinicalTrials.gov (NCT05947045)
Actively enrolling

Studies you may be able to join near Memphis

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Memphis

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Baptist Clinical Research Institute

6025 Walnut Grove Rd #500, Memphis, TN 38120
(901) 226-1821

Clinical trials in Memphis: what's recruiting

The Memphis area currently has 583 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Memphis, the most active research areas are:

  • Cancer & Oncology15 studies
  • Heart & Vascular2 studies
  • Lungs & Breathing1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Memphis, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Memphis

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Memphis participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Memphis?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Memphis, TN?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Memphis?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Memphis.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Memphis typically complete one or two studies per year.

Paid clinical trials near Memphis

Other metros within reach

Little Rock, AR513 Jackson, MS224 Clarksville, TN8 Tuscaloosa, AL23 Huntsville, AL95 Nashville, TN1,336 St. Louis, MO1,513 Birmingham, AL984

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Memphis Bladder Issues Due To Spinal Cord Injury in Memphis All conditions

More of TN

Nashville1,336 Knoxville236 Chattanooga139 Murfreesboro79 Clarksville8

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts